Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 272 clinical trials
featured
The Intra-arterial Vasospasm Trial - A Multicenter Randomized Study

The primary objective of the study is to determine the optimal intra-arterial drug treatment regimen for arterial lumen restoration post cerebral vasospasm following

  • 0 views
  • 12 Aug, 2020
  • 1 location
featured
A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein

lung carcinoma
crizotinib
lung cancer
  • 98 views
  • 23 Nov, 2020
  • 1 location
featured
Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma

Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab In Patients With Follicular Non-Hodgkin’s Lymphoma

  • 590 views
  • 23 Nov, 2020
  • 5 locations
featured
Phase 1/2 Study Of Intratumoral G100 With Or Without Pembrolizumab or Rituximab In Patients With Follicular Non-Hodgkin’s Lymphoma

intratumorally at the maximum safe dose determined in Part 1 following local radiation or will receive the same treatment regimen sequentially administered with pembrolizumab. A second treatment group may be

lymphoma
non-hodgkin's lymphoma
lymphomas
  • 73 views
  • 22 Dec, 2020
  • 31 locations
featured
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

The purpose of this study is to evaluate the efficacy and safety of pemigatinib in participants with previously treated locally advanced/metastatic or surgically unresectable solid tumor malignancies harboring activating FGFR mutations or translocations.  

FGFR3
primary tumor
cancer
solid tumor
malignancy
  • 46 views
  • 14 Dec, 2020
  • 62 locations
featured
Raise your hand if you have type 2 diabetes

Raise your hand if you have type 2 diabetes

  • 64 views
  • 08 Nov, 2020
  • 1 location
featured
A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Disease

A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Disease

  • 184 views
  • 25 Mar, 2021
  • 1 location
featured
A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, in Combination With PD-L1 Inhibitor, Durvalumab, in Advanced or Metastatic Solid Tumors and Non Small Cell Lung Cancer

  • 314 views
  • 25 Mar, 2021
  • 4 locations
  • 0 views
  • 14 Apr, 2021
  • 58 locations
A Randomized Double Blinded Comparison of Ceftazidime and Meropenem in Severe Melioidosis

treatment regimen. A key question is whether alternative antibiotics could improve early outcome. The hypothesis tested is that meropenem is superior to ceftazidime in terms of mortality for the

  • 5 views
  • 07 Nov, 2020
  • 1 location